389 related articles for article (PubMed ID: 17848919)
1. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.
Nasrallah HA
Mol Psychiatry; 2008 Jan; 13(1):27-35. PubMed ID: 17848919
[TBL] [Abstract][Full Text] [Related]
2. Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.
Reynolds GP; Kirk SL
Pharmacol Ther; 2010 Jan; 125(1):169-79. PubMed ID: 19931306
[TBL] [Abstract][Full Text] [Related]
3. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
Baptista T; Kin NM; Beaulieu S; de Baptista EA
Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
[TBL] [Abstract][Full Text] [Related]
4. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
Silvestre JS; Prous J
Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
[TBL] [Abstract][Full Text] [Related]
5. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
Kuroki T; Nagao N; Nakahara T
Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotics and the burden of disease.
Simpson GM
Am J Manag Care; 2005 Sep; 11(8 Suppl):S235-41. PubMed ID: 16180961
[TBL] [Abstract][Full Text] [Related]
7. Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome.
Shirzadi AA; Ghaemi SN
Harv Rev Psychiatry; 2006; 14(3):152-64. PubMed ID: 16787887
[TBL] [Abstract][Full Text] [Related]
8. Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects.
Jafari S; Fernandez-Enright F; Huang XF
J Neurochem; 2012 Feb; 120(3):371-84. PubMed ID: 22103329
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer JW
J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic agents in the treatment of bipolar mania.
Tohen M; Vieta E
Bipolar Disord; 2009 Jun; 11 Suppl 2():45-54. PubMed ID: 19538685
[TBL] [Abstract][Full Text] [Related]
11. Metabolic side effects of atypical antipsychotics in children: a literature review.
Fedorowicz VJ; Fombonne E
J Psychopharmacol; 2005 Sep; 19(5):533-50. PubMed ID: 16166191
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
Compton MT; Miller AH
Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
[TBL] [Abstract][Full Text] [Related]
13. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Meltzer HY; Huang M
Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
Vohora D
Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
[TBL] [Abstract][Full Text] [Related]
15. Receptor pharmacology of neuroleptics: relation to clinical effects.
Richelson E
J Clin Psychiatry; 1999; 60 Suppl 10():5-14. PubMed ID: 10340682
[TBL] [Abstract][Full Text] [Related]
16. Sexual dysfunction in schizophrenia: focus on recent evidence.
Baggaley M
Hum Psychopharmacol; 2008 Apr; 23(3):201-9. PubMed ID: 18338766
[TBL] [Abstract][Full Text] [Related]
17. [Critical review of mechanisms of action of second-generation antipsychotic drugs].
Miyamoto S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):199-208. PubMed ID: 17240845
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic safety and efficacy concerns.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.
Heusler P; Newman-Tancredi A; Loock T; Cussac D
Eur J Pharmacol; 2008 Feb; 581(1-2):37-46. PubMed ID: 18190908
[TBL] [Abstract][Full Text] [Related]
20. Abnormal glucose metabolism in patients treated with antipsychotics.
Scheen AJ; De Hert MA
Diabetes Metab; 2007 Jun; 33(3):169-75. PubMed ID: 17412628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
